Brief: Immunovia Q3 Adjusted EPS SEK -0.91
09/11/2023 07:34
Nov 9 (Reuters) - Immunovia Q3 adjusted free cash flow SEK -35 million. * Q3 net income SEK -38.6 million * Q3 adjusted EPS SEK -0.91 * Q3 revenue SEK 488 thousand
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study